# Methotrexate

NDC: 61703-124
Generic name: Methotrexate
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20221017

FDA application: NDA011719

## Active ingredients

- METHOTREXATE SODIUM: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61703-124"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61703-124
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd287e89-32f9-4396-95fa-4b562869f476